Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk

Summary

This large-scale genomic study, drawing on multiple international cohorts, identified hundreds of genetic variants influencing the timing of menarche in women. The authors analysed these associations to propose biological pathways linking early puberty to elevated cancer risk, as suggested by the genomic architecture. The findings contribute to understanding how developmental timing may influence long-term health outcomes, though the clinical or dietary implications remain indirect.

UK applicability

The study's findings on genetic predisposition to early menarche and cancer risk are applicable to understanding population-level health patterns in the United Kingdom. However, the work is primarily genetic/mechanistic rather than actionable for farming systems or food-based interventions, limiting direct relevance to agricultural policy or farming practice.

Key measures

Genetic variants (single nucleotide polymorphisms) associated with age at menarche; cancer risk phenotypes correlated with puberty timing

Outcomes reported

The study identified hundreds of genetic variants associated with age at menarche through genome-wide association analysis. The findings suggest a mechanistic link between puberty timing and subsequent cancer risk in women.

Topic tags